Related references
Note: Only part of the references are listed.Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply precision medicine to antimicrobial chemotherapy?
Federico Perez et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Fosfomycin: Resurgence of an old companion
Sangeeta Sastry et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals — United States, 2014
Lindsey M. Weiner et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Intravenous Fosfomycin Treatment for Carbapenem-Resistant Klebsiella pneumoniae in the United States
Jacques Simkins et al.
ANNALS OF PHARMACOTHERAPY (2015)
Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
F. Docobo-Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
Suzanne L. Parker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Jesus Rodriguez-Bano et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2015)
Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China
Yan Jiang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
E. Shaw et al.
BMJ OPEN (2015)
Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-beta-lactamase-producing Klebsiella oxytoca
Salvador Vergara-Lopez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Nosocomial infections in the intensive care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India
Sugata Dasgupta et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2015)
Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Efficacy and Safety of Fosfomycin Plus Imipenem as Rescue Therapy for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Multicenter Clinical Trial
Ana del Rio et al.
CLINICAL INFECTIOUS DISEASES (2014)
Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
Konstantinos Pontikis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a Chinese teenager: case report and literature review
Jie Chen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
C. Navarro-San Francisco et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis
Jose M. Miro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin
Anucha Apisarnthanarak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Fosfomycin: Efficacy against infections caused by multidrug-resistant bacteria
Aurelien Dinh et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
David M. Livermore
KOREAN JOURNAL OF INTERNAL MEDICINE (2012)
High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report
Liang-Yu Chen et al.
BMC INFECTIOUS DISEASES (2011)
Adverse events associated with intravenous fosfomycin
Amelie Florent et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Antibiotic time-lag combination therapy with fosfomycin for postoperative intra-abdominal abscesses
Shinya Kusachi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2011)
Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
Souha S. Kanj et al.
MAYO CLINIC PROCEEDINGS (2011)
In Vitro Activity of Fosfomycin against bla(KPC)-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Use of High-Dose 4-Hour Infusion of Doripenem, in Combination with Fosfomycin, for Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Pneumonia
Anucha Apisarnthanarak et al.
CLINICAL INFECTIOUS DISEASES (2010)
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
Wang-Huei Sheng et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus
Xu-Hong Yu et al.
JOURNAL OF ANTIBIOTICS (2010)
Extracellular concentrations of fosfomycin in lung tissue of septic patients
Veronika Matzi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Appropriate vs. inappropriate antimicrobial therapy
P. G. Davey et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections:: Analysis of trends in prevalence and epidemiology
E Tacconelli et al.
EMERGING INFECTIOUS DISEASES (2002)
Share Paper
